Sign In
Buy TMDX
$71.37
+1.68 (+2.41%)
At Close: Jun 04, 2026
TransMedics: Wide Moat Player At A Lower Valuation Than Peers
06:05am, Tuesday, 10'th Sep 2024
TransMedics is revolutionizing organ transportation with its FDA-approved Organ Care System, improving organ functionality during transport. Significant investments in logistics, including owning airc
Why Shares of TransMedics Stock Plunged This Week
04:50pm, Thursday, 05'th Sep 2024
TransMedics' one-year beta is ballooning, meaning the stock is becoming increasingly more volatile. Furthermore, a growing number of traders are betting against the stock.
TransMedics (TMDX) Is Up 3.16% in One Week: What You Should Know
01:01pm, Friday, 30'th Aug 2024
Does TransMedics (TMDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Take the Zacks Approach to Beat the Markets: Vista Gold, TransMedics, Accenture in Focus
10:46am, Monday, 26'th Aug 2024
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
04:05pm, Wednesday, 21'st Aug 2024
ANDOVER, Mass. , Aug. 21, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Tuesday, 20'th Aug 2024
ANDOVER, Mass. , Aug. 20, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics Group, Inc. (TMDX) Hit a 52 Week High, Can the Run Continue?
10:15am, Tuesday, 20'th Aug 2024
TransMedics (TMDX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
1 No-Brainer Growth Stock I Can't Wait to Buy Again if the Market Crashes
05:13am, Sunday, 11'th Aug 2024
Recently, U.S. stock markets have been more volatile than usual. TransMedics stock has surged thanks to revenue that has more than doubled this year.
TransMedics (TMDX) Recently Broke Out Above the 20-Day Moving Average
10:36am, Friday, 09'th Aug 2024
TransMedics (TMDX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TMDX crossed above the 20-day moving average, suggesting a
Betting Big On TransMedics (Q2 2024 Update)
03:36pm, Thursday, 08'th Aug 2024
TransMedics Group, Inc. reported 117.9% YoY revenue growth in Q2 2024 and raised full-year guidance significantly, showcasing strong financial performance. Acquisition of Summit Aviation and building
Can TransMedics (TMDX) Run Higher on Rising Earnings Estimates?
01:20pm, Wednesday, 07'th Aug 2024
TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Q3's Rising Stars: 3 Growth Stocks for Your Must-Watch List
11:26am, Monday, 05'th Aug 2024
Over the past years, AI and GLP-1 stocks have been the major themes that have drawn the most attention. However, plenty of other investments have been working and flying under the radar in this market
TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy
09:25am, Sunday, 04'th Aug 2024
TransMedics Group had a remarkable second quarter, beating revenue estimates and raising guidance. The company's National Organ Care Systems Program is driving growth, with liver revenues up 2.4x and
New Strong Buy Stocks for August 2nd
08:22am, Friday, 02'nd Aug 2024
SVM, IBCP, TMDX, WT and YELP have been added to the Zacks Rank #1 (Strong Buy) List on August 2, 2024.
Compared to Estimates, TransMedics (TMDX) Q2 Earnings: A Look at Key Metrics
09:02pm, Thursday, 01'st Aug 2024
The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim
